Inhibition of proliferation and invasion of breast cancer stem cells/Reduction of ALDH1A1, CXCR4, EpCAM and MUC1 protein levels/Induction of MDA-MB-231 cell cycle arrest in G2/M phase. Here, MUC1 is linked to breast carcinoma.